Drugs / IOP
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02744248 Comparator | Feb → Dec 2016 | — | MegaPro Biomedical Co. Ltd. | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IOP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02744248 ↗ |
| Known as | IOP Injection | “IOP Injection 20 mg Fe/ml, intravenous injection” NCT02744248 ↗ |
| Modality | Diagnostic / imaging agent | “IOP magnetic resonance imaging (MRI) contrast agent” NCT02744248 ↗ |
| Route | Intravenous | “IOP Injection 20 mg Fe/ml, intravenous injection” NCT02744248 ↗ |